Search Results - "García‐Suárez, Julio"

Refine Results
  1. 1
  2. 2
  3. 3

    SARS-CoV-2-Specific T Lymphocytes Analysis in mRNA-Vaccinated Patients with B-Cell Lymphoid Malignancies on Active Treatment by García Ramírez, Patricia, Callejas Charavia, Marta, Oliva Martin, Raquel, Gómez La Hoz, Ana María, Ortega, Miguel Ángel, García Suárez, Julio, Álvarez-Mon, Melchor, Monserrat Sanz, Jorge

    Published in Vaccines (Basel) (26-08-2024)
    “…Patients with B-lymphocyte malignancies (BCMs) receiving B-lymphocyte-targeted therapies have increased risk of severe COVID-19 outcomes and impaired antibody…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study by García-Suárez, Julio, de la Cruz, Javier, Cedillo, Ángel, Llamas, Pilar, Duarte, Rafael, Jiménez-Yuste, Víctor, Hernández-Rivas, José Ángel, Gil-Manso, Rodrigo, Kwon, Mi, Sánchez-Godoy, Pedro, Martínez-Barranco, Pilar, Colás-Lahuerta, Blanca, Herrera, Pilar, Benito-Parra, Laurentino, Alegre, Adrián, Velasco, Alberto, Matilla, Arturo, Aláez-Usón, María Concepción, Martos-Martínez, Rafael, Martínez-Chamorro, Carmen, Susana-Quiroz, Keina, Del Campo, Juan Francisco, de la Fuente, Adolfo, Herráez, Regina, Pascual, Adriana, Gómez, Elvira, Pérez-Oteyza, Jaime, Ruiz, Elena, Alonso, Arancha, González-Medina, José, Martín-Buitrago, Lucía Núñez, Canales, Miguel, González-Gascón, Isabel, Vicente-Ayuso, María Carmen, Valenciano, Susana, Roa, María García, Monteliu, Pablo Estival, López-Jiménez, Javier, Escobar, Cristián Escolano, Ortiz-Martín, Javier, Diez-Martin, José Luis, Martinez-Lopez, Joaquín, Serí-Merino, Cristina, Queiroz-Cervantes, Keina, Fernandez, Mónica Estévez, Peñalva-Moreno, María-José, Naya-Errea, Daniel, Bermejo-Martínez, Laura, Llorente-González, Laura

    Published in Journal of hematology and oncology (08-10-2020)
    “…Abstract Background Patients with cancer have been shown to have a higher risk of clinical severity and mortality compared to non-cancer patients with…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    HCV‐associated thrombocytopenia: clinical characteristics and platelet response after recombinant α2b‐interferon therapy by GarcíaSuárez, Julio, Burgaleta, Carmen, Hernanz, Nuria, Albarran, Fernando, Tobaruela, Pedro, Alvarez‐Mon, Melchor

    Published in British journal of haematology (01-07-2000)
    “…Hepatitis C virus (HCV) has been proposed as a possible causative agent of chronic thrombocytopenia. We investigated HCV infection in a series of 51 unselected…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Changes in the natural history of progressive multifocal leukoencephalopathy in HIV‐negative lymphoproliferative disorders: Impact of novel therapies by GarcíaSuárez, Julio, de Miguel, Dunia, Krsnik, Isabel, Bañas, Helena, Arribas, Ignacio, Burgaleta, Carmen

    Published in American journal of hematology (01-12-2005)
    “…The aims of this study were to evaluate the clinical characteristics of HIV‐negative patients affected by lymphoproliferative disorders (LPD) who developed…”
    Get full text
    Journal Article
  20. 20

    Myelodysplastic syndrome with erythroid hypoplasia/aplasia: A case report and review of the literature by GarcíaSuárez, Julio, Pascual, Teresa, Muñoz, M. Angeles, Herrero, Begoña, Pardo, Ana

    Published in American journal of hematology (01-08-1998)
    “…Myelodysplastic syndrome (MDS) with erythroid hypoplasia/aplasia has not yet been clearly defined, and in most patients it is mistaken for acquired pure red…”
    Get full text
    Journal Article